|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Cancer Institute (NCI) |
|---|---|
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00001823 |
Purpose
Patients with a suspected or proven malignant disease (cancer) will be admitted to this study to be evaluated for suitability in a clinical trial of the National Cancer Institute's Surgery Branch.
No experimental treatments will be administered in this study; its purpose is solely to evaluate patients for eligibility in other NCI Surgery Branch trials. In rare cases, patients who are ineligible for a current study may nevertheless be admitted for standard treatment because their condition represents a unique training or research experience.
Patients will undergo various tests and procedures, depending on the study for which they are being considered. The tests may include, but not be limited to, various blood tests, such as HLA tissue typing and hepatitis screening; imaging tests such as PET, MRI and CT scans, and procedures such as pulmonary function tests, arteriogram, tumor biopsy, and laparoscopy.
| Condition |
|---|
|
Cancer |
| Study Type: | Observational |
| Official Title: | Evaluation for NCI Surgery Branch Clinical Research Protocols |
| Estimated Enrollment: | 5000 |
| Study Start Date: | June 1999 |
Background:
Potential research candidates undergo thorough screening including laboratory tests, scans, x-rays and review of pathology slides to determine initial eligibility for Surgery Branch research protocols.
Objectives:
To permit evaluation of patients referred to the NCI Surgery Branch in order to identify individuals who will be suitable candidates for Surgery Branch clinical research protocols.
Eligibility:
Patient suspected of having, or with biopsy proven malignant disease.
Patient, parent or guardian (if a minor), is able to provide informed consent.
Design:
Patients enrolled on this protocol will be evaluated by NCI Surgery Branch physicians to determine the individual's suitability for participation in a clinical research protocol. An accrual ceiling of 5000 patients has been set to meet the screening needs of the Surgery Branch.
Eligibility| Ages Eligible for Study: | 16 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Patients suspected of having, or with biopsy proven malignant disease.
Patient, parent or guardian (if a minor), is able to provide informed consent.
EXCLUSION CRITERIA:
Candidates who do not meet the inclusion criteria.
Contacts and Locations| Contact: Recruitment Center - SB | (866) 820-4505 | ncisbirc@mail.nih.gov |
| Contact: June Kryk, R.N. | (301) 451-1929 | ncisbirc@mail.nih.gov |
| United States, Maryland | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
| Bethesda, Maryland, United States, 20892 | |
| Sub-Investigator: NCI/Surgery Branch Recruitment Center For more information at the NIH Clinical Center contact | |
More Information
| ClinicalTrials.gov Identifier: | NCT00001823 History of Changes |
| Obsolete Identifiers: | NCT00019799 |
| Other Study ID Numbers: | 990128, 99-C-0128 |
| Study First Received: | November 3, 1999 |
| Last Updated: | December 30, 2011 |
| Health Authority: | United States: Federal Government |
|
Screening Eligibility Diagnostic Testing Standard Treatment Clinical Training |
